Wed Jan 28 Kazia Therapeutics Reports Encouraging Preliminary Clinical Responses in Ongoing Phase 1b Study of Paxalisib in Late-Stage Metastatic Triple-Negative Breast Cancer Written by PR Newswire Asia - News Pronto RSS Enable JavaScript and cookies to continueRead more http://www.prnasia.com/story/archive/4871636_CN71636_0
